Drug intelligence / Profile preview

human umbilical cord mesenchymal stem cells (Limin Rong)

Development stage
Unknown
Lead developer
The Third Affiliated Hospital of Sun Yat-sen University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intrathecal
01

Overview

This is an investigational cell therapy consisting of allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) being developed by Limin Rong and colleagues at The Third Affiliated Hospital of Sun Yat-sen University. The therapy is specifically designed for the treatment of spinal cord injury (SCI), including both complete and incomplete injuries in the early chronic phase. Administered via repeated intrathecal (subarachnoid) injections, the hUC-MSCs exert therapeutic effects through multiple paracrine and cellular pathways, including the inhibition of neuroinflammation, regulation of apoptosis, promotion of revascularization, and the release of neurotrophic factors to facilitate spinal cord repair and functional recovery.

Other names
hUC-MSCsallogeneic human umbilical cord mesenchymal stem cells

Beyond the preview

Go deeper on human umbilical cord mesenchymal stem cells (Limin Rong).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human umbilical cord mesenchymal stem cells (Limin Rong).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call